23 related articles for article (PubMed ID: 17451356)
1. A Simple and Efficient Genetic Immunization Protocol for the Production of Highly Specific Polyclonal and Monoclonal Antibodies against the Native Form of Mammalian Proteins.
Pelletier J; Agonsanou H; Manica F; G Lavoie E; Salem M; Luyindula P; Babou Kammoe RB; Sévigny J
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992862
[TBL] [Abstract][Full Text] [Related]
2. DNA immunization as a technology platform for monoclonal antibody induction.
Liu S; Wang S; Lu S
Emerg Microbes Infect; 2016 Apr; 5(4):e33. PubMed ID: 27048742
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of XBP1(S) in human B-cell lymphomas.
Maestre L; Tooze R; Cañamero M; Montes-Moreno S; Ramos R; Doody G; Boll M; Barrans S; Baena S; Piris MA; Roncador G
Haematologica; 2009 Mar; 94(3):419-22. PubMed ID: 19176362
[TBL] [Abstract][Full Text] [Related]
4. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
[TBL] [Abstract][Full Text] [Related]
5. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
[TBL] [Abstract][Full Text] [Related]
6. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Okabe M; Inagaki H; Ohshima K; Yoshino T; Li C; Eimoto T; Ueda R; Nakamura S
Am J Pathol; 2003 Apr; 162(4):1113-22. PubMed ID: 12651604
[TBL] [Abstract][Full Text] [Related]
7. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
8. Generation of a new monoclonal antibody against MALT1 by genetic immunization.
Maestre L; Fontan L; Martinez-Climent JA; Garcia JF; Cigudosa JC; Roncador G
Hybridoma (Larchmt); 2007 Apr; 26(2):86-91. PubMed ID: 17451356
[TBL] [Abstract][Full Text] [Related]
9. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
Afonina IS; Elton L; Carpentier I; Beyaert R
FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
[TBL] [Abstract][Full Text] [Related]
10. Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?
Demeyer A; Staal J; Beyaert R
Trends Mol Med; 2016 Feb; 22(2):135-150. PubMed ID: 26787500
[TBL] [Abstract][Full Text] [Related]
11. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
